Search

In this work, rapamycin-eluting poly (d, l-lactic acid) coating (PDLLA/RAPA) was prepared on biodegradable Mg-Nd-Zn-Zr alloy (JDBM) for both in vitro and in vivo investigation of the degradation behaviors of the magnesium alloy stent platform. Electrochemical tests and hydrogen evolution test demonstrated significant in vitro protection of the polymeric coating against magnesium degradation both in short and long term. The 3-month in vivo study on the RAPA-eluting JDBM stent implanted into porcine coronary arteries confirmed its favorable safety, and in the meanwhile revealed similar neointima proliferation compared to the second generation DES Firebird 2 with no occurrence of adverse complications. Moreover, Micro-CT examination combined with IVUS and OCT detection indicated a remarkably lower degradation rate and prolonged radial supporting duration of the drug-eluting JDBM stent as compared to the bare, attributable to the protection of the coating in vivo. Hence, rapamycin-eluting JDBM stents exhibit great potential for clinical application.

Biomedical Mg alloy is promising for its widespread use clinically. In vitro and in vivo studies showed that the degradation products of biomedical Mg alloy were composed of O, P, Ca, Mg and other alloying elements. However, little is known about the metabolism of the degradation products. In this study, the in vitro macrophage phagocytosis of the degradation products of a biomedical Mg-Nd-Zn-Zr alloy was directly observed. This result affirms the necessity to investigate the long-term fate of Mg alloy degradation products in physiological environments. Besides, an electrochemical method was proposed to prepare enough amount of degradation products in vitro efficiently.

Electrospun fiber scaffolds, due to their mimicry of bone extracellular matrix (ECM), have become an important biomaterial widely applied in bone tissue engineering in recent years. While topographic cues of electrospun membranes such as alignment and diameter played vital roles in determining cellular behaviors. Yet few researches about the effects of these two significant parameters on osteogenesis have been reported. Thus, the present work explored the influence of aligned and random poly (L-lactic acid) (PLLA) fiber matrices with diameters of nanoscale (0.6 μm) and microscale (1.2 μm), respectively, on cellular responses of bone marrow mesenchymal stem cells (BMSCs), such as cell adhesion, migration, proliferation and osteogenesis. Our results revealed that aligned nanofibers (AN) could affect cell morphology and promote the migration of BMSCs after 24 h of cell culturing. Besides, AN group was observed to possess excellent biocompatibility and have significantly improved cell growth comparing with random nanofibers. More importantly, in vitro osteogenesis researches including ALP and Alizarin Red S staining, qRT-PCR and immunofluorescence staining demonstrated that BMSCs culturing on AN group exhibited higher osteogenic induction proficiency than that on aligned microfibers (AM) and random fiber substrates (RN and RM). Accordingly, aligned nanofiber scaffolds have greater application potential in bone tissue engineering.

In the present study, the effects of Zn-3Cu-xFe (x = 0, 0.2, 0.5 wt%) alloys on endothelial cells (EA.hy926) and smooth muscle cells (A7r5), the hemocompatibility and antibacterial properties were also evaluated. The cell viability of EA.hy926 cells and A7r5 cells decreased with the increasing of extract concentration. At the same Zn2+ concentration (over 6 ppm), the cell viability of EA.hy926 cells increased with the addition of Cu or Cu and Fe content, but no significant effect on A7r5 cells was observed. The hemolysis rate of Zn-3Cu-xFe alloys samples was about 1%, and there was no adversely affected on platelets adhering to the surface of the Zn alloys. As Fe content increases in the Zn-Cu-Fe alloys, the antibacterial lower concentrations against Staphylococcus aureus and Escherichia coli was improved due to the higher degradation rate and more Zn2+ and Cu2+ released. Our previous study already showed that the Zn-Cu-Fe alloy exhibited excellent mechanical properties and moderate degradation rate. Based on the above results, the in vitro biocompatibilities and antibacterial properties of Zn-3Cu alloy are significantly improved by the alloying of trace Fe, and the hemocompatibility is not adversely affected, which indicated that Zn-Cu-Fe alloy is a promising vascular stents candidate material.

Development of bone graft substitutes with appropriate integration of mechanical, biodegradable, and biofunctional properties, which promote bone formation while simultaneously preventing implant-associated infections, remains a great challenge. Herein we designed and synthesized a brushite/Ag3PO4-coated Mg-Nd-Zn-Zr scaffolds through chemical solution deposition of a composite coating onto the fluorinated Mg-based scaffolds generated with template replication method. The coated Mg-based open-porous scaffolds exhibit hierarchically-structured surface with cube-shaped Ag3PO4 nanoparticles uniformly distributed on top of microsized brushite grains. Immersion test reveals that the initial degradation rate of the coated scaffolds could be reduced by ~81% compared to the original scaffolds. The mean corrosion rate in 4 weeks falls into 0.10–0.15 mm/year to meet clinical requirements. The compatibility and ALP activity of cells grown in the extracts from the coated Mg-based scaffolds were increased compared with Ti control and original scaffolds, mainly due to the favorable microenvironment generated by Mg biodegradation. Besides, the coated Mg-based scaffold demonstrated potent antimicrobial activity via the synergistic actions of alkaline degradation products of Mg and the Ag species in the coating, achieving >99.5% antibacterial rate against both gram-positive and gram-negative bacteria with relatively low silver content. Taken together, this study presents a new candidate of brushite/Ag3PO4-coated Mg-based scaffold with appropriate degradation characteristics, cytocompatibility, and antimicrobial activities for bone tissue engineering applications.

To further improve the corrosion resistance and biocompatibility of Mg–Nd–Zn–Zr alloy (JDBM), a biodegradable calcium phosphate coating (Ca–P coating) with high bonding strength was developed using a novel chemical deposition method. The main composition of the Ca–P coating was brushite (CaHPO 4 ·2H 2 O). The bonding strength between the coating and the JDBM substrate was measured to be over 10 MPa, and the thickness of the coating layer was about 10–30 μm. The in vitro corrosion tests indicated that the Ca–P treatment improved the corrosion resistance of JDBM alloy in Hank's solution. Ca–P treatment significantly reduced the hemolysis rate of JDBM alloy from 48% to 0.68%, and induced no toxicity to MC3T3-E1 cells. The in vivo implantation experiment in New Zealand's rabbit tibia showed that the degradation rate was reduced obviously by the Ca–P treatment and less gas was produced from Ca–P treated JDBM bone plates and screws in early stage of the implantation, and at least 10 weeks degradation time can be prolonged by the present coating techniques. Both Ca–P treated and untreated JDBM Mg alloy induced bone growth. The primary results indicate that the present Ca–P treatment is a promising technique for the degradable Mg-based biomaterials for orthopedic applications.